Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

9.30
+0.02000.22%
Post-market: 9.300.00000.00%19:30 EDT
Volume:112.14K
Turnover:1.03M
Market Cap:281.38M
PE:-1.60
High:9.48
Open:9.16
Low:8.86
Close:9.28
52wk High:11.00
52wk Low:5.60
Shares:30.26M
Float Shares:12.40M
Volume Ratio:1.47
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7983
EPS(LYR):-5.0200
ROE:-7029.26%
ROA:-17.43%
PB:-2.25
PE(LYR):-1.85

Loading ...

Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Correspondence

Form CORRESP - Correspondence
Jan 06, 2025

Correspondence

Form CORRESP - Correspondence
Jan 06, 2025

Correspondence

Form CORRESP - Correspondence
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]